Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells

Biochemical Journal

Volumn 360, Issue 2, 2001, Pages 363-370

  Rasmussen, L M ^a   Hansen, P R ^a   Nabipour, M T ^a   Olesen, P ^a   Kristiansen, M T ^a   Ledet, T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endocytosis; Endothelium; Mevastatin; NF B; Shedding

Indexed keywords

CELLS; ENZYME INHIBITION; MOLECULES; PROTEINS; TUMORS;

TUMOR NECROSIS;

BIOCHEMISTRY;

COMPACTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MEVALONIC ACID; STATINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSCRIPTION REGULATION;

CELL MEMBRANE; CELLS, CULTURED; CYTOKINES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HALF-LIFE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MEMBRANE PROTEINS; MEVALONIC ACID; NF-KAPPA B; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0035587158     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3600363     Document Type: Article

References (39)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
3. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
4. Statins do more than just lower cholesterol
5. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis
6. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
7. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
8. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
9. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
10. Atherosclerosis - An inflammatory disease
11. Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses
12. Selectins and their ligands: Current concepts and controversies
13. Identification of an inducible endothelial-leukocyte adhesion molecule
14. Monocyte adherence to human vascular endothelium
15. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque
16. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice
17. NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation
18. Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process
19. Evidence for endocytosis of E-selectin in human endothelial cells
20. Divergent fates of P- and E-selectins after their expression on the plasma membrane
21. Phosphorylation of surface E-selectin and the effect of soluble ligand (sialyl Lewis x) on the half-life of E-selectin
22. A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells
23. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
24. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase
25. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins
26. NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment
27. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers
28. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells
29. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
30. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells
31. Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases
32. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
33. Cytoplasmic domain of E-selectin contains a non-tyrosine endocytosis signal
34. Selectin-carbohydrate interactions during inflammation and metastasis
35. Mechanisms that regulate the function of the selectins and their ligands
36. Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells
37. Memory B lymphocytes from secondary lymphoid organs interact with E-selectin through a novel glycoprotein ligand
38. Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton
39. Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte-endothelial adhesion